AIWorldNewz.com

FDA Approves Leucovorin for Autism Treatment

Source: F.D.A. to Relabel Leucovorin for Autism Treatment (2025-09-22)

The FDA has approved leucovorin as a treatment for children with autism spectrum disorder (ASD), marking a significant development in autism care. The decision follows promising clinical trial results indicating that leucovorin can improve social and communication skills in some children with ASD, offering a new therapeutic option for families and clinicians. Researchers highlight that leucovorin, a form of folate, appears to address underlying biological factors associated with autism. While not a cure, the medication provides hope for targeted intervention, especially for children who have not responded well to existing therapies. The approval underscores ongoing efforts to develop personalized treatments based on biological markers in autism.

More recent coverage